Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

Experimental Hematology

Volumn 28, Issue 12, 2000, Pages 1413-1422

  Greiner, Jochen ^a   Ringhoffer, Mark ^a   Simikopinko, Oliver ^a   Szmaragowska, Anita ^a   Huebsch, Sandra ^a   Maurer, Ulrich ^a   Bergmann, Lothar ^a   Schmitt, Michael ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute myeloid leukemia; Leukemia associated antigens; MAZ; PRAME; SEREX

Indexed keywords

LEUKEMIA ANTIGEN; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOLUNTEER; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD34; ANTIGENS, NEOPLASM; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE LIBRARY; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034541547     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00550-6     Document Type: Article

References (35)

1. T cell activation determined by T cell receptor number and tunable thresholds
2. Her-2/neu derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes
3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
4. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
5. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
6. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
7. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
8. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
9. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1; definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
10. Expression of SSX genes in human tumors
11. Induction and persistence of complete remission in a resistant acute myeloid leukemia patient after treatment with recombinant interleukin-2
12. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity
13. The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-β 1
14. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses
15. Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody
16. A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias
17. Serological identification of human tumor antigens
18. Characterization of human colon cancer antigens recognized by autologous antibodies
19. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome
20. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma; candidates for T-cell-based immunotherapies
21. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells
22. A tumor-associated antigen expression in human haematological malignancies
23. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
24. A new lim protein containing an autoepitope homologous to 'senescent cell antigen.'
25. Identification of several genes differentially expressed during progression of chronic myelogenous leukemia
26. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination
27. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters
28. The many roles of c-myc in apoptosis
29. Pathogenesis of ovarian cancer
30. Genomic organization and expression of a human gene for myc-associated zinc finger protein (MAZ)
31. Structural organization and expression of the mouse gene for PUR-1, a highly conserved homolog of the human MAZ gene
32. Rejection Antigen peptides on BALB/c Rlmale1 leukemia recognized by cytotoxic T lymphocytes; derivation from the normally untranslated 5′ region of the c-akt proto-oncogene activated by long terminal repeat
33. HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia
34. Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors
35. HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide